rs267606877
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM1PM2PP3PP5
The NM_022489.4(INF2):c.556T>C(p.Ser186Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars). Synonymous variant affecting the same amino acid position (i.e. S186S) has been classified as Likely benign.
Frequency
Consequence
NM_022489.4 missense
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth disease dominant intermediate EInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
- focal segmental glomerulosclerosis 5Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- familial idiopathic steroid-resistant nephrotic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| INF2 | NM_022489.4 | c.556T>C | p.Ser186Pro | missense_variant | Exon 4 of 23 | ENST00000392634.9 | NP_071934.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| INF2 | ENST00000392634.9 | c.556T>C | p.Ser186Pro | missense_variant | Exon 4 of 23 | 5 | NM_022489.4 | ENSP00000376410.4 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Focal segmental glomerulosclerosis 5 Pathogenic:1
- -
INF2-related disorder Pathogenic:1
The INF2 c.556T>C variant is predicted to result in the amino acid substitution p.Ser186Pro. This variant has been reported to be pathogenic for autosomal dominant focal segmental glomerulosclerosis (FSGS); and this variant has been shown to likely increase INF2 interaction with profilin 2 and the F-actin capping protein, resulting in aberrant regulation of actin dynamics (Brown et al. 2010. PubMed ID: 20023659; Rollason et al. 2016. PubMed ID: 26764407). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at